Ribonucleic acid / krebs

Ribonucleic acid aptamer having inhibitory effect on non-small cell lung cancer and pharmaceutical composition comprising same

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

TECHNICAL FIELD The present invention belongs to the field of biotechnology, and more particularly, to a ribonucleic acid aptamer having an inhibitory effect on non-small cell lung cancer and a pharmaceutical composition comprising the same. BACKGROUND ART Cancer has become one of the leading causes

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum to detect, monitor or evaluate cancer or premalignant conditions

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to proteins which contain amino acid sequences that bind to 3'-untranslated regions of mRNAs, particularly mRNA sequences containing "instability sequences" and sequences affecting the translation and localization of

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to proteins which contain amino acid sequences that bind to 3'-untranslated regions of mRNAs, particularly mRNA sequences containing "instability sequences" and sequences affecting the translation and localization of

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to proteins which contain amino acid sequences that bind to 3'-untranslated regions of mRNAs, particularly mRNA sequences containing "instability sequences" (Shaw et al, Cell (1986) 46: 659-667). 2. Discussion of the

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

REFERENCE TO A SEQUENCE LISTING This application refers to a "Sequence Listing" listed below, which is provided as an electronic document entitled "Sequence.txt" (9 kb created on Nov. 30, 2017) which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Prostate cancer

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

REFERENCE TO A SEQUENCE LISTING This application refers to a "Sequence Listing" listed below, which is provided as an electronic document entitled "Sequence.txt" (8 kb created on Nov. 5, 2016) which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Prostate cancer

Short interfering RNA for treating cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION 1. Field of the Invention The present disclosure relates to treatments for cancers. More particularly, the disclosure relates to treating cancer by use of novel double-stranded short interfering nucleic acid that inhibits the translation of Aurora-A mRNA. 2. Description

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Nur registrierte Benutzer können Artikel übersetzen

Einloggen Anmelden

BACKGROUND OF THE INVENTION Ribonucleic acid (RNA) is essential to the processes which allow translation of the genetic code to form proteins necessary for all cellular functions, both in normal and neoplastic cells. While the genetic code structurally exists as deoxyribonucleic acid (DNA), it is

ribonucleic acid/krebs

Ribonucleic acid aptamer having inhibitory effect on non-small cell lung cancer and pharmaceutical composition comprising same

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma or serum to detect, monitor or evaluate cancer or premalignant conditions

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Methods of using PVT1 exon 9 to diagnose and treat prostate cancer

Short interfering RNA for treating cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird